Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Thousand US dollars).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Recruitment and project wins in Japan, stronger leadership in Southeast Asia, economic growth in India, new revenue in the Operational Transformation area from the consolidation of the Renoir Group, steady performance in animal hospital operations and the acquisition of an animal hospital operating company, and a temporary gain from the sale of shares in an investee company contributed to higher revenue and profit. On the other hand, aggressive hiring, the reorganisation of personnel and locations in the Supply Chain Solutions business, temporary costs related to profitability improvement measures, and the sale of the Singapore food and beverage business contributed to lower profit and revenue in some businesses.
None (the notes on going concern state that there are no applicable matters)
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | 64,403 Thousand US dollars (YoY +35.7%) |
| Operating profit | 3,890 Thousand US dollars (YoY +35.5%) |
| Ordinary income | 3,657 Thousand US dollars (YoY +47.7%) |
| Profit attributable to owners of the parent | 2,024 Thousand US dollars (YoY +65.1%) |
| Net income per share | ¥14.71 (basic) |
| Equity ratio | End of the current fiscal period 54.9% / End of previous period 56.8% |
| Total assets | 147,565 Thousand US dollars |
| Net assets | 82,339 Thousand US dollars |
| Cash flows from operating activities | -3,470 Thousand US dollars |
| Cash flows from investing activities | 1,483 Thousand US dollars |
| Cash flows from financing activities | -12,837 Thousand US dollars |
| Cash and cash equivalents at end of period | 21,189 Thousand US dollars |
| Full-year earnings forecast | Net Sales 129,412 Thousand US dollars (YoY +22.4%) / Operating profit 8,537 Thousand US dollars (YoY +7.5%) / Ordinary income 8,451 Thousand US dollars (YoY +17.0%) / Net income 5,458 Thousand US dollars (YoY +30.4%) |
| Annual Dividend Forecast | US$0.09 (¥14.62, actual for the fiscal year ended December 2025) → US$0.12 (¥19.49, forecast for the fiscal year ending December 2026) |
| Segment revenue | 24,001 Thousand US dollars, 25,497 Thousand US dollars, 10,298 Thousand US dollars, 5,993 Thousand US dollars |
| Segment profit | 2,987 Thousand US dollars, 634 Thousand US dollars, 1,162 Thousand US dollars, 1,615 Thousand US dollars |
| Regional sales | 9,394 Thousand US dollars (YoY +50.7%), 5,862 Thousand US dollars (YoY +17.5%), 2,745 Thousand US dollars, 6,002 Thousand US dollars (YoY +7.5%), 743 Thousand US dollars, 707 Thousand US dollars, -2,115 Thousand US dollars, 23,338 Thousand US dollars |
| Depreciation and amortization | 2,511 Thousand US dollars |
| Disclosure regarding the going concern assumption | None (the notes on going concern state that there are no applicable matters) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors, media representatives and individual investors) |
| Issued Shares at Period-End | 22,349,092 |
| Treasury Shares at Period-End | 0 |
| Factors Behind Changes in Business Performance | Recruitment and project wins in Japan, stronger leadership in Southeast Asia, economic growth in India, new revenue in the Operational Transformation area from the consolidation of the Renoir Group, steady performance in animal hospital operations and the acquisition of an animal hospital operating company, and a temporary gain from the sale of shares in an investee company contributed to higher revenue and profit. On the other hand, aggressive hiring, the reorganisation of personnel and locations in the Supply Chain Solutions business, temporary costs related to profitability improvement measures, and the sale of the Singapore food and beverage business contributed to lower profit and revenue in some businesses. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Management Services business, recruitment and project wins in Japan, stronger leadership in Southeast Asia, and economic growth in India contributed to higher revenue, while aggressive hiring led to lower profit. In the Professional Solutions business, higher revenue across each area and sales in the Operational Transformation area from the consolidation of the Renoir Group contributed to higher revenue, but temporary costs associated with profitability improvement measures led to lower profit. In the Pet Care area, results were affected by steady performance in animal hospital operations and the acquisition of a company in July 2025. In the Strategic Investment area, results were affected by a temporary gain from the sale of shares in an investee company.